医学
化疗
危险系数
内科学
肿瘤科
肺癌
放射治疗
置信区间
免疫疗法
癌症
作者
Kaiyue Ding,Minhan Yi,Hui Liang,Zhongkui Li,Yuan Zhang
标识
DOI:10.1080/1744666x.2022.2088510
摘要
Both single ICI plus chemotherapy and doublet ICIs were probably better treatment decisions than chemotherapy alone for negative PD-L1 NSCLC patients. Also, single ICI plus radiotherapy carved out a new strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI